Taiwan's biotechnology industry is making a significant impact at the 2024 BIO International Convention in San Diego. Organized by the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) under the Ministry of Economic Affairs, the Taiwan delegation includes representatives from various gov...
PhD, with the 2024 AACR-Cancer Research Institute (CRI) Lloyd J. Old Award in Cancer Immunology during theAACR Annual Meeting 2024to be held April 5-10 at the San Diego Convention Center in San Diego, California. Freeman is a Professor of Medicine in...
SAN DIEGO, Jan. 30, 2024 (GLOBE NEWSWIRE) --Bionano Genomics, Inc. (BNGO) today announced the conclusion of Bionano’s 2024 Symposium, the quintessential event for the optical genome mapping (OGM) community,...
Our proprietary BIO One-on-One Partnering match-making platform - included in the Premier Access registration package - allows you to find potential partners, schedule and accept meetings. Website: https://www.bio.org/events/bio-international-convention ...
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected candidates from its oncology pipeline at the American Association for Cancer Research (“AACR”) Annual Meeting 2024 in San Diego, California, from
San Diego, CA – November 14, 2024 –HUYABIO International today announced the presentation of new patient data for HBI-3000, an antiarrhythmic drug (AAD) with a unique protective profile for the treatment of atrial fibrillation (AF), one of the most common and serious heart conditions worldwi...
has announced that its subsidiary, Anaergia Technologies LLC, secured a change order to provide more engineering services and supply of equipment as part of an ongoing project in East San Diego County, California. Read More Air Burners hosts demonstration event featuring the BioCharger By ...
an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs, announced the forthcoming presentations of new preclinical research and clinical trial data from its oncology program, D3S-001, at the 2024 AACR Annual Meeting in San Diego, Cal...
倫敦、日內瓦和澤西島聖赫利爾,2024年4月8日 /PRNewswire/ — 歐洲領先的生命科學投資公司Medicxi今天宣佈向總部位於中國上海的生物技術公司D3 Bio投資4000萬美元。D3 Bio專注於腫瘤學和免疫學創新藥物的發現、開發和註冊。這項投資將加速D3 Bio創新腫瘤化合物產品線的開發。Medicxi合夥人弗朗切斯科·德魯伯蒂斯將加入...
SAN DIEGO--(BUSINESS WIRE)-- Boundless Bio, Inc. (Nasdaq: BOLD), a clinical stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced the pricing of its initial public...